Concepedia

Iris Rajman

IR

Statistics

Publications

19

Citations

756

H-Index

16

Active since

1996

Affiliations

Novartis (Switzerland)(Current)

Novartis (India)

Novartis (United States)

Novartis Institutes for BioMedical Research

Queen Elizabeth Hospital Birmingham

Iris Rajman is an author at Novartis (Switzerland) specializing in clinical pharmacology, pharmacology, and medicine.

ORCID

Publications per year

1996–2017

19

Publications

19

The effect of LCZ696 (sacubitril/valsartan) on amyloid‐β concentrations in cerebrospinal fluid in healthy subjects

Thomas Langenickel, Chiaki Tsubouchi, Surya Ayalasomayajula et al. · British Journal of Clinical Pharmacology · 2015 · 109 citations · Full text

, , +14

Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men

Iris Rajman, M. J. Kendall, Robert Cramb et al. · Atherosclerosis · 1996 · 107 citations

, , +16

Low-density lipoprotein subfraction profiles in chronic renal failure

Iris Rajman · Nephrology Dialysis Transplantation · 1998 · 81 citations · Full text

, , +15

Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (<scp>LCZ</scp>696) in Patients with Heart Failure and Reduced Ejection Fraction

Zhanna Kobalava, Yu. V. Kotovskaya, Diego Albrecht et al. · Cardiovascular Therapeutics · 2016 · 80 citations · Full text

, , +17

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor

Lu Gan, Thomas Langenickel, Jesika Petruck et al. · The Journal of Clinical Pharmacology · 2015 · 46 citations

, , +16

1–5 of 19